Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Articles published by Actinogen Medical

News headline image
Final, 247th participant randomized and commences treatment in Actinogen’s XanaMIA pivotal phase 2b/3 Alzheimer’s trial
From Actinogen Medical
Via GlobeNewswire
Tickers ASX:ACW
News headline image
Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
From Actinogen Medical
Via GlobeNewswire
Tickers ASX:ACW
News headline image
Actinogen provides pivotal Alzheimer’s trial enrolment update and other business news
From Actinogen Medical
Via GlobeNewswire
Tickers ASX:ACW
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.